Investigation of nanoscale drug particles and their effect on the fluid dynamic properties of the blood by Slats, Jason L.
INVESTIGATION OF NANOSCALE DRUG PARTICLES AND THEIR EFFECT ON THE 
FLUID DYNAMIC PROPERTIES OF THE BLOOD
By
Jason L. Slats, B.S.
A project report submitted in partial fulfillment of 
the requirements for the degree of
Master of Science 
in
Mechanical Engineering
University of Alaska Fairbanks 
May 2020
APPROVED:
Debendra Das, Committee Chair 
Lei Zhang, Committee Co-Chair 
Debasmita Misra, Committee Member 
Rorik Peterson, Chair
Department of Mechanical Engineering
Abstract
Research has shown that gold nanoparticles increase the efficiency of radiation treatments of 
cancer by up to 25%. This means patients can be exposed to lower doses of radiation that does 
more concentrated damage to cancerous cells and less damage to healthy surrounding tissue. 
Before these nanoparticles can be introduced to the human body, the behavior of these particles 
in the blood stream must be understood. A model of gold nanoparticle flow through the aortic 
arch was developed in the present investigation for predicting behavior of these particles in the 
human body.
A set of initial modeling parameters was developed out of existing data pertaining to blood flow 
rates and viscosities of a blood-mimicking fluid across a temperature range of 30-40 degrees 
Celsius. The aorta wall was modeled as a no-slip solid surface. Computational fluid dynamic 
models using ANSYS Fluent across this temperature range have generated general velocity 
distributions of blood flow through the aortic arch and identifies several areas of possible 
recirculation. The current state of the model provides preliminary results, which are valuable in 
generating an accurate model of gold nanoparticles flowing through the aortic arch.
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Chapter 1: Introduction
1.1 Nanotechnology in T reating  C ancer
Cancer has directly or indirectly affected numerous living beings, including many Alaskans. 
Research from the Alaska Native Tribal Health Consortium shows that cancer is the leading 
cause of death among Alaska Native populations (at a rate 10-20 percent higher than the national 
average). Advances in technology offer the potential for cancer and disease treatment. 
Nanotechnology is becoming increasingly widespread in today’s industries including the field of 
biomedicine. Research has shown that gold nanoparticles introduced to cancerous tissue can 
improve effectiveness of killing those cancer cells with radiation by up to 25% [1]. During the 
course of their research, Antosh et al [1] determined a stable material with a high atomic number 
would be ideal for this application. They applied gold nanoparticles to samples of cancerous 
lung tissue in vitro and irradiated them with an x-ray machine.
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Figure 1: Samples o f  cancerous lung tissue with gold nanoparticles
Figure 1 shows samples of cancerous lung tissue with gold nanoparticles under a microscope. 
Sample A shows gold nanoparticles alone, while samples B-D utilize nanoparticles that were 
functionalized to bond with a protein that bounces off of healthy tissue and attaches itself to 
diseased tissue [1]. The enhanced destruction of the cancer cells comes from the Auger Effect, 
in which energy from the x-ray causes an electron in the outer shell of the gold nanoparticle to
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move to a higher energy shell. This causes another electron from an outer shell to be ejected into 
the surrounding cancerous tissue [1].
Applying nanotechnology in this way requires an understanding of how the human body will 
react to these nanoparticles. To help achieve this understanding, a computational fluid dynamic 
model of blood flow through the aortic arch could be developed using ANSYS Fluent. The 
modeling presented here represents how changes to viscosity of the fluid over a temperature 
range affect the velocity profiles of blood through the aortic arch. However, further investigation 
into how other thermophysical properties (density, thermal conductivity, and specific heat) are 
affected by the introduction of nanoparticles into the blood stream is required for a 
comprehensive study. In a cancer treatment application, gold nanoparticles may not flow 
through the heart. Flow through the aortic arch was chosen to model for its relatively simple 
geometry. When the model is refined, it can then be applied to more complex geometries where 
cancer tumors will be treated.
The area being modeled starts above the 
coronary arteries, covers the entire arch 
including the three main artery branches on 
the top, and down the descending aorta to a 
point even with the starting point. The 
relatively simple geometry of this section will 
be used to refine the CFD model so that it can 
then be applied to more complex geometries.
Figure 2: Diagram courtesy o f University o f California 




1.2 Nanofluids L ite ra tu re  Review
Das, Choi, Yu and Pradeep [2] conducted significant research into the nature of and applications 
of nanofluids. Nanofluids are created by dispersing nanoscale solid particles into a fluid. The 
average size of these nanoparticles is generally below 100 nm. Extensive research has been 
conducted on how these types of fluids affect heat transfer. The intent of this research is to 
extract the most efficiency from a nanofluid with respect to thermal properties with the lowest 
concentration of nanoparticles in the fluid [2].
Figure 3:3 nm Gold Nanoparticles Synthesized by Chemical Reaction [2]
Cao and Wang [3] describe a variety of ways in which nanoparticles can be synthesized. There 
are several goals to consider when generating nanoparticles. The nanoparticles should all be of 
similar size and shape. The nanoparticles should also have the same chemical composition and 
structure and should not easily agglomerate. The particles should be easily separated if 
agglomeration does occur. Homogeneous nucleation is a method of nanoparticle synthesis in 
which generation occurs in a supersaturated solution. Nuclei are formed in the solution and 
growth occurs. Size and uniformity of the nanoparticles is determined by close control of the 
nucleus formation and subsequent growth. Metallic nanoparticles can be synthesized by 
reduction reactions of metallic compounds in a solution. Size of the nanoparticles using this 
method are controlled by the concentration of the solute and the introduction of a polymeric 
monolayer onto the growth surface to inhibit formation of nuclei. Hydrolysis is another method
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of generating metal oxides in a solution. As the solution becomes oversaturated, the nucleation 
occurs [3].
There has been significant research into use of nanoparticles in the biomedical field. Sharifi, 
Shokrallahi, and Amiri [4] examined the properties of ferrite-based magnetic nanofluids. These 
types of fluids have possible uses in a form of cancer treatment called hyperthermia. 
Hyperthermia is simply the heating of cancerous regions using radio waves, microwaves, or 
lasers. Cancer cells are more susceptible to damage from heat than normal cells, so if these 
nanoparticles could be deployed to a localized area where cancerous cells are growing then 
hyperthermic treatments could be more effective [4].
Any deployment of nanoparticles for biomedical purposes will require functionalization of the 
nanoparticle with a protein or antibody. Rahme and Holmes [5] conducted a study on the 
bioconjugation of 60, 90, and 150 nm gold nanoparticles with an amino group of the 
apolipoprotein (ApoE) protein in water. This was accomplished using a functional oligomer 
based on ethylene glycol, thiol disulfide, and N-hydroxy succinimide [5].
Figure 4: Formation o f gold nanoparticles functionalized with ApoE Protein [5].
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Figure 5: Gold nanoparticle with protein adsorption [6]
Understanding how these nanoparticles affect the human body is an important consideration 
before any biomedical trials involving living subjects can be implemented. Alkilany and 
Murphy [6] examined the nanotoxicity of gold. Gold is nonreactive and are already used in 
clinical settings as arthritis treatments, but gold nanoparticles are not currently used on human 
patients. Alkilany and Murphy [6] found that more research is required to understand gold 
nanoparticle toxicity. Studies on this topic have had conflicting results. No toxicity was found 
in mice for 3-5 nm gold nanoparticles and gold nanoparticles in the 50-100 nm range. 
Nanoparticle sizes in between these ranges were lethal to the mice and resulted in major internal 
organ damage. However, in vitro tests conducted with nanoparticles in the harmful 18-37 nm 
range were not found to be lethal. In all cases, gold nanoparticles were found in the liver and 
spleen after injection. Gold nanoparticles from the smaller size range were found in the brain 
and lungs as well [6]. Cedervall et al. [7] also showed that nanoparticles in the blood stream will 
adsorb to the surface of the nanoparticle changing its properties and behaviors as it becomes 
covered with the surrounding proteins.
Aggarwal et al.[8] explain that this adsorption of proteins to the nanoparticle happens as soon as 
the nanoparticle is in the biological system. A gold nanoparticle is a foreign object and subject 
to the body’s biological response to its presence in the system. There is further study required to 
understand the protein binding and the effects this binding has on nanoparticle distribution,
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biocompatibility of the nanoparticle, and the effect this bonding has on the biomedical value of 
the nanoparticle [8].
“Polysorbate Coated” Particle ApoE Bound
Figure 6: Bound proteins to several types o f particles
1.3 Blood Viscosity
It is important to understand the properties of blood in order to understand how it flows. The 
Standard Handbook of Biomedical Engineering and Design [9] is an excellent reference for this 
information. Although blood is a non-Newtonian fluid, it is worth noting that in large arteries 
blood behaves as a Newtonian fluid.
du
T = K - i ; >
(i)
Equation 1 indicates shear stress (r) is a linear function of blood viscosity (u) where u is 
velocity and r  is the distance from the aortic wall [9]. In smaller arteries the shear stress is not 
linear with the shear rate and acts as a non-Newtonian fluid. Equation 2 describes this 
relationship where K  is a constant and n is greater than 0 [9].
6
/  d u \r 
= K { - ^ )
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1.4 G overning E quations of the Fluid Dynam ic M odel
Since blood flow through large arteries can be characterized as Newtonian flow, the Navier- 
Stokes equation in cylindrical coordinates can be applied to describe the fluid flow. Equation 3 
is the continuity equation and equations 4-6 are the momentum equations in the r, theta, and z 
directions [10].
1 3  1 3  3 (3)
~ — (rvr) + - ^ ( v e) + ^ ~ (vz) = 0 
r or r 39 oz
dvr 1 9 1dp  _ vr 2 dvg (4)
—— + (V • V)vr — v g = — —  + gr + v(V vr — j  — 2 ~aa') ot r a p or r 2 r 2 o9
dv6
dt + ( V^) Vg
vrv e 1 dp Vg 2 dvr
+ 9 e +  V(V v e - - J  +p d9 r 2 r 2 39 )
(5)
dvz 1dp  (6)
—  + (V- V) vz = - - -  + g z + v Viv z
Additional work using the Navier-Stokes equation to develop a one-dimensional model for 
arterial flow was developed by Formaggia, Lamponi, and Quarteroni [11]. They used a 
numerical method approach to average the Navier-Stokes equation across the different sections 
of the blood vessel. Similarly, Ghigo et al. [12] developed a 1-D non-Newtonian blood flow
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model to be applied in smaller diameter blood vessels where a Newtonian assumption cannot be 
made. Equations 7 and 8 show the conservation of mass and momentum equations for the 1 -D 
non-Newtonian system with an elastic boundary [12].
dA 9Q (7)
dt dx
Here A represents the cross-sectional area and Q is the axial flow rate.
(8)a +  "a-  ( ~a + a—A2 ,dt d x \ A  2p )  p
In Equation 8, K  is the rigidity of the arterial wall and xrx is the wall shear stress. Shear stress is 
directly linked to viscosity via Equation 1. This means that fluid viscosity plays a major role in 
studying the flow characteristics of a fluid. Extensive research has been conducted in 
determining how viscosity is affected by the addition of nanoparticles to a fluid.
1.5 Nanofluids Viscosity C orrelations
In 1906, Einstein [13] developed a correlation for viscosity of a liquid “in which very many 
irregularly distributed small spheres are suspended.” Equation 9 is his equation for determining 
the viscosity of this suspension based on the viscosity of the base fluid and the volume fraction 
(^) of the particles in the fluid where k* is the viscosity of the suspension and k is the viscosity 
of the base fluid.
k* = k ( 1 - 2 . 5 p )  (9)
Following Einstein’s lead was De Brujin [14] who modified Einstein’s equation as shown in 
Equation 10. Here, peff  is the viscosity of the mixture and pbf  is the viscosity of the base fluid 
while 0  is the volume fraction of the particles in the base fluid.
_  (  1 (10)
keff k b f [ 1 - 2 . 5  (P + 1.552<P2)
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Vladimir Vand [15] developed an equation that introduced a term to account for interaction 
between particles. He made the assumption that the particles will stay together for a short time 
and act as a single larger particle. The equation he came up with was only valid to the first term 
for this interaction. His equation is shown as Equation 11 [15].
Me// =Mb/( 1 - 2 . 5  0  + 7.34902 ...) (11)
M. Mooney [16] built upon Einstein’s equation to apply to a suspension with a finite 
concentration of particles. This expression includes a constant K  called the self-crowding factor. 
Mooney’s equation is shown below.
(  2.50 (12)
Me/ / = M b /  exP ( 1 - ^ 0 2j
In 1952, Brinkman [17] developed an equation that became widely used although it did not 
introduce any new terms. Brinkman’s equation is shown below.
Me// Mb/ ( ( 1 - 0 )2)
(13)
1.6 P roperties of Blood Vessel W alls
The blood vessels themselves have important characteristics. The arterial wall is composed of 3 
separate layers containing very different types of cells. The innermost layer, the intima, is made 
up of cells that keep the blood cells separated from the outer 2 layers of the vessel wall. The 
middle (and largest) layer is called the media. The media primarily consists of muscle cells with 
elastin and some collagen. Collagen is also found in the outermost layer of the vessel wall, the 
adventitia. Each layer is separated by a very thin elastic layer. Figure 7 shows clearly the
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detailed layers of the wall [18]. For the purpose of creating a more realistic wall for a 
computational fluid dynamic model, each layer does not have to be individually created and 
assigned material properties. Several studies have been conducted that measure the mechanical 
properties of arteries and blood vessels.
Figure 7: Blood Vessel Layers http://sphweb.bumc.bu.edu/otlt/MPH- 
Modules/PH/PH709_Heart/BloodVessel-structure.jpg
A team from the University of Madrid carried out stress testing on human coronary arteries. 
They were able to obtain samples from 5 brain-dead patients aged between 23 and 83. The 
patients did not suffer from any coronary disease. Each sample was at least 50 mm long, and 
uniaxial loading was applied at a rate of 0.03 mm/s until one of the layers mentioned above 






a = — 
a
(16)
Symbols for equations 14-16 are defined as follows:
A is stretch, I is current length, and L is initial length. The value a is current cross-sectional area 
and A is initial cross-sectional area. a  is true stress and P is applied load. Results from the 5 
samples were not similar enough to derive a single stretch-stress relationship across all samples. 
A general relationship is described by the stretch/stress plot in Figure 8.
Figure 8: General Stress/Stretch relationship found in each sample after uniaxial 
testing
The plot can be broken down into 2 separate regimes. The first section of the plot defined from 1 
to Ae shows the region where the elastin in the artery wall dominates the response to the applied 
load [3]. The coordinate (Ae, ae) was defined by the researchers as the midpoint where the first 
derivative of the plot in Figure 8 transitions from the first general elastic modulus to the second
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much higher modulus. That second region is where the response to the applied load is 
dominated by the collagen layer of the artery wall [19].
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Figure 9: Elbow stresses across 5 samples [19]
Figure 9 represents the elbow stress point (it is the same as the transition point in Figure 8) of 
each of the 5 samples. Examining how the elbow stress fits into the overall stretch/stress plot in 
Figure 8, it is obvious that there is great deviation across each sample, and that a single usable 
value to apply to the mechanical properties o f a model is not possible from this data set. Figure 9 
shows that there is a five-fold increase in elbow stress as the age increases from 20 to 80.
Researchers from the Department of Mechanical Engineering and the Department of Biomedical 
Engineering in collaboration with researchers from the Division of Cardiothoracic Surgery at 
Washington University in St. Louis Missouri were able to perform both planar biaxial loading 
and strength testing on samples taken from 64 patients who were being treated for Marfan 
Syndrome. This is an excellent example of collaborative research between engineering and 
medicine faculty. According to the Marfan Foundation, Marfan Syndrome is a genetic disorder 
that may cause enlargement of the aorta and other connective tissue. Although the tissue
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samples collected for this study may not represent healthy systems, the data collected during the 
study contributes to the understanding of the mechanical properties of arterial walls. It should be 
noted that the researchers performed a 3rd qualitative test to compare residual circumferential 
stress in the aorta between patients. However, since this was a qualitative test it will not 
contribute to the numerical values for mechanical properties needed for the computational fluid 
dynamics model and will not be discussed here.
Results of the uniform biaxial loading tests at Washington University were similar to what was 
found in the University of Madrid experiments. Figure 10 shows results from 2 of the 64 
samples taken. The stiffer stress response (circles •)  is from a sample provided by a 65-year-old 
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Figure 10: Stress/Strain plots provided by a 65 year old patient and a 49 year old patient [20]
Overall, results were too scattered to find a single average elastic modulus to apply to a 
mathematical model. However, Equation 17 calculates the failure stress based upon the strength 
tests conducted in the study [20].
af [MPa] = 2.875 -  0.023(Age [Years]) (17)
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This equation can be used as a general estimate o f what the failure stress will be. The limitation 
is this correlation only has an R2 value of 0.44.
1.7 S ummary  of D ifferent C hap ters of this R eport
Chapter 2 will provide viscosity data for blood. This data will be used as the input functions 
for viscosities o f a blood-like fluid across a range of temperatures and gold nanoparticle 
concentrations.
Chapter 3 will present the ANSYS Fluent modeling conducted for this research.
Chapter 4 will provide the conclusion and recommendations for future work.
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Chapter 2: Viscosity of Blood Like Fluid
2.1 Viscosity Equations
A value for blood viscosity is required in order to develop a flow model for blood through the 
aortic arch. Although blood is known to be a non-Newtonian fluid, in many preliminary studies 
it is modeled as a Newtonian fluid when it is flowing through a large main artery. The flow also 
is an average blood velocity rather than the actual pulsatile flow found in the human body.
Viscosities from 30 degrees Celsius to 40 degrees Celsius were used in the model using the
following equation for determining viscosities of a blood-like fluid based on temperature in 
degrees Celsius [1]:
g = 0.0041T2 - 0 . 3 3 1 8 T + 9.6544 (18)
This equation was developed by Yousif, Holdsworth, and Poepping [1] who synthesized a blood 
mimicking fluid and experimentally determined viscosity, g , in centipoise, of the fluid at 
temperatures between 20 and 27 deg C. Figure 11 shows their experimental results. The dashed 
line shows viscosity and the solid line is the refractive index for the Blood Mimicking Fluid 
(BMF). The following is the equivalent of centipoise (cP) in terms of SI units.
g kg
1 poise (P) = 1 — —  = 100 cP = 0.1—^—
cm * s m * s
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Figure 11:Experimental results fo r  viscosity o f  a blood mimicking flu id  [1]
Viscosities of the BMF between 30 and 40 degrees Celsius are tabulated below.
Table 1: Viscosities o f a blood mimicking fluid from 30 to 40 degrees Celsius












The blood mimicking fluid developed by earlier researchers is a mixture of water, glycerol, and 
sodium iodide. Glycerol is chemically very similar to ethylene glycol. Equations that have been 
developed for viscosity of ethylene glycol based nanofluids are appropriate to implement here.
In 2007, Namburu, Kulkarni, Misra, and Das [2] experimentally determined the correlation for 
an ethylene glycol based nanofluid to be the following based on the volume concentration (0 ) :
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l o g o f f )  = Ae BT (19)
The temperature of the nanofluid, T, is in Kelvin. The values for A and B are functions of 
volume concentration as shown in equations 20 and 21.
A = 1.837502 -  29.6430 + 165.56 (20)
B = 4.8*  1O- 6(0 ) 2 -  0.0010 + 0.0186 (21)
In 2009, Sahoo et al. [3] extended the temperature range of viscosity measurements and updated 
the viscosity correlation to:
, „ f = ^ ( ^ )  (22)
A, B, and C are not functions of volume concentration, but constants based on the temperature 
range of the nanofluid in Kelvin. The figure below shows the experimental data used to 
determine these constants.
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Figure 12:Experimental data fo r  nanofluid viscosity [3]
The Table 2 defines the values of A, B, and C for the 2 temperature ranges developed by Sahoo 
et al.
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Table 2: Variable values fo r  Equation 22 in high and low temperature ranges [3]
Variable Low Range (238-273 K) High Range (273-363 K)




In 2009, Vajjha, Das, and Namburu [4] further improved the viscosity correlation by non- 
dimensionalizing the viscosities of the nanofluid and the base fluid. The results are shown in 
Equation 23.
^HL = Ae(c^) (23)
R-bf
The values for A and C in Equation 23 are constants determined by the type of nanofluid under 
examination. Since the effect of gold nanoparticles on the viscosity of an glycerol based blood 
mimicking fluid is being examined, and the chemical makeup of glycerol is very similar to that 
of ethylene glycol, the correlation developed by Vajjha, Das, and Namburu was selected to 
examine gold nanoparticle effects on the viscosity of the blood mimicking fluid. The constants 
A and C for Aluminum Oxide were used as a first approximation for these calculations because 
no constants for gold nanoparticles were available in the literature. The values for A and C are 
0.983 and 12.959 respectively. In the future, gold nanoparticles should be dispersed in the BMF 
and viscosity measurements should be made to improve predictions.
2.2 Blood M im icking Fluid Viscosity Calculations
The equation developed by Vajjha, Das, and Namburu [4] was applied to calculated values for 
blood mimicking fluid viscosity from 30 to 40 degrees Celsius. Table 3 shows the effects of 
nanoparticle introduction to blood viscosity.
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30.000 3.390 3.794 4.319 4.916 5.597 6.371
30.500 3.349 3.747 4.265 4.856 5.527 6.292
31.000 3.309 3.702 4.215 4.798 5.462 6.217
31.500 3.271 3.660 4.167 4.743 5.399 6.146
32.000 3.235 3.620 4.121 4.691 5.340 6.079
32.500 3.202 3.583 4.078 4.642 5.285 6.016
33.000 3.170 3.547 4.038 4.597 5.233 5.957
33.500 3.140 3.514 4.000 4.554 5.184 5.901
34.000 3.113 3.483 3.965 4.514 5.138 5.849
34.500 3.087 3.455 3.933 4.477 5.096 5.801
35.000 3.064 3.429 3.903 4.443 5.058 5.757
35.500 3.043 3.405 3.876 4.412 5.022 5.717
36.000 3.023 3.383 3.851 4.384 4.990 5.681
36.500 3.006 3.364 3.829 4.359 4.962 5.648
37.000 2.991 3.347 3.810 4.337 4.937 5.620
37.500 2.978 3.332 3.793 4.318 4.915 5.595
38.000 2.966 3.319 3.779 4.302 4.897 5.574
38.500 2.957 3.309 3.767 4.288 4.882 5.557
39.000 2.950 3.301 3.758 4.278 4.870 5.544
39.500 2.945 3.296 3.752 4.271 4.862 5.535
40.000 2.942 3.293 3.748 4.267 4.857 5.529
As expected, the introduction of gold nanoparticles to the fluid significantly increases viscosity 
as the concentration increases from 0% to 5%. At a concentration of 5%, the calculated viscosity 
is almost double that of the base fluid by itself. Note that a concentration of 5% would likely not 
be introduced into a patient. Since it’s been shown that gold nanoparticles of any size will 
accumulate in the internal organs of the host (including the brain if the particles are small 
enough), any amount of gold nanoparticles introduced to a patient for therapeutic purposes 
would be of negligible concentration. Figure 13 gives a visual representation of the variation in 
viscosity with an increase in temperature and nanoparticle volumetric concentration. Most 
liquids display a characteristic of diminishing viscosity with an increase in temperature. This 
gold nanofluid is also displaying the same behavior in Figure 13.
22
Figure 13:Viscosity vs Temperature o f Blood Mimicking Fluid fo r  0-5% volume concentration
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Chapter 3: Computational Modeling of Nanofluid Flow
3.1 M odel Equations
Using the governing equations provided in Equations 3-6 listed under Section 1.4, ANSYS 
Fluent CFD Code Version 19.1 was used to model nanofluid flow through the aorta. The density 
was supplied to the code via the nanofluid equation provided by Pak and Choi [1].
Pnf Pbf(1 + Pp& (23)
pnf  is the density of the nanofluid, pbf  is the density of the base fluid, 0  is volumetric
koconcentration, and pp is the density of the particle. The density of gold is known to be 19300 —
and the density of blood is known to be about 1025 —  [2]. The viscosity was provided to the 
simulation from Table 3 presented in Chapter 2.
3.2 A orta  G eom etry
The geometry for the aortic arch is a 2-dimensional construct that captures the entering flow 
region coming from the heart, three exit flow regions at the top of the aortic arch that represent 
the subclavian and carotid arteries, and the main exit flow region of the descending aorta. A 
survey of anatomy references was conducted, and a wide variety of values for the diameters of 
each section is reported. The following set of values was used as they fell well within the 
minimum and maximum values in the existing data available [3] [4]:
Table 4: Diameters used in the model fo r  the various arterial branches
Area Diameter (mm)
Left Subclavian Artery 9.04
Left Carotid Artery 7.15
Brachiocephalic Artery 12.07
Ascending Aorta 32.58
Aortic Arch Width (center to center) 79.00
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Figure 14: Image o f  the aortic arch and related arteries [5]
The area being modeled starts above the coronary arteries, covers the entire arch including the 
three main artery branches on the top, and down the descending aorta to a point even with the 
starting point. The preliminary selection of this geometry can be improved to refine the CFD 
model so that it can then be applied to more complex geometries. The surface properties applied 
to the aorta walls was simply a no-slip boundary condition on solid surfaces. The inlet boundary 
condition is a uniform velocity and pressure, and the outlet boundary condition used in the model 
was the percentage of output flow through each outgoing flow boundary. The values shown in 
Table 5 were derived from outlet conditions determined in previous research of a larger section 
of the aorta [6].
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Table 5:Flow rate ratings fo r  each flow  output location
Outflow Location Flow Rate Weighting
Brachiocephalic Artery 0.15
Left Subclavian Artery 0.075
Left Carotid Artery 0.075
Descending Aorta 0.70
Once all of these input parameters were entered into the ANSYS Fluent model, cases were run 
for the base fluid viscosity from 30 to 40 degrees Celsius in 1-degree Celsius increments. The 
computations produced velocity contours and velocity vector results, which are discussed 
subsequently.
3.3 Results
Using the post processing capability of ANSYS Fluent, graphics showing the velocity contours 
and the velocity vector fields were generated for each temperature listed in Table 3. Some 
results are highlighted here. However, each case is provided in Appendix A. Figure 15 below 
shows the initial results based on a crude mesh used with a viscosity value of 4.4 cP, which can 
represent 3% nanofluid at 35 degrees Celsius. This first run showed large areas with very little 
flow. This may be due to the incorrect selection of computational domain. The 3 branch arteries 
are modeled too short so that flow does not get a chance to be fully developed in them, whereas 
in actual cases the branches are long enough to produce fully developed flows.
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Figure 15:First case run with initial geometry and crude mesh showing velocity contours. The velocity scale is in meters per second.
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A viscosity using Equation 18 was applied to a second run with a more refined mesh and with 
the branching arteries elongated to provide space for the flow to fully develop. Figure 16 shows 
the resulting velocity contour. Once the model parameters were settled, the cases from 30 to 40 
degrees Celsius were all run in 1-degree Celsius increments. Figures 17-20 show the velocity 
contours and vector fields for viscosities at 30 degrees Celsius and 40 degrees Celsius for 
comparison. Most of the velocity profiles remained very similar across the range of 
temperatures and viscosities. Small changes in the shape of the velocity contours are evident 
when a graphic is created that runs through each case. The velocity values tend towards the 
bottom end of spectrum due to using an average rate of blood flow rather than pulsatile flow, 
where peaks of up to 120 cm/s have been measured [7]. The velocity vector fields were of 
particular interest. Where the velocity contours may show an area where flow is approaching 
negligibly small velocity, the velocity vector field shows more clearly what is occurring. Figure 
21 clearly shows an area of recirculation inside the Brachiocephalic artery where gold 
nanoparticles may congregate. These are areas to be further scrutinized when trying to 
determine how the gold nanoparticles will be affected by the motion of the blood.
The simulations presented in this study are for entry Reynolds numbers in the neighborhood of 
700. Therefore, all the models are for laminar flow conditions. These velocity distribution 
diagrams prove that blood will accelerate (along with nanoparticles) to reach highest velocity 
magnitude in a region just prior to the entrance to the Brachiocephalic artery.
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Figure 16: Elongated arteries and refined mesh
30
Figure 17: Velocity contours at 30 degrees Celsius
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Figure 18: Velocity vector fie ld  at 30 degrees Celsius
32
Figure 19: Velocity contour at 40 degrees Celsius
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Figure 20:Velocity vector fie ld  at 40 degrees Celsius
34
Figure 21: Close up view o f  velocity vectorfield in Brachiocephalic artery at 40 degrees Celsius showing recirculation.
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Chapter 4: Conclusion and Recommendations
4.1 Conclusion
Gold nanoparticles show great promise in the biomedical field as a way to increase certain 
cancer treatment efficiencies [1]. Before these nanoparticles can be deployed in a patient’s body, 
the behavior of these nanoparticles in the blood stream will need to be understood and predicted. 
Although gold is a relatively stable element, on a nanoscale these particles will infiltrate internal 
organs including the brain. Functionalizing the nanoparticle and bonding it with antibodies is a 
possible avenue of controlling behavior of these nanoparticles, but an effective method of 
removing these particles from the body would be required. Developing a model of blood flow 
through the body is a first step in being able to understand how gold nanoparticles will behave in 
the body and to deploy these particles for medical reasons. It is evident from these preliminary 
results that there are areas of recirculation in the blood flow where gold nanoparticles could 
potentially congregate.
Equations have been developed to predict how nanoparticles change the thermophysical 
properties of a fluid. This has been extensively studied in water, and propylene glycol/water and 
ethylene glycol/water mixtures. These equations can be applied to blood to see what effect these 
particles will have on the intrinsic fluid properties of blood. The focus here was on viscosity, 
and it was demonstrated that viscosity will increase with the addition of nanoparticles as 
expected.
4.2 R ecom m endations
This set of models is a good initial step to creating an accurate model of blood flow with gold 
nanoparticles through the aortic arch. Areas of possible recirculation have been identified and 
general velocity profiles and vector fields have been generated. However, there are quite a few 
improvements that need to be made in order to create a more accurate model.
In this case, only viscosity was changed in order to define the fluid properties of the model. 
Values of specific heat, thermal conductivity, and density should be determined for the 
temperature range and applied to the fluid properties in the model. A data set describing these 
properties for blood over a temperature range is not currently readily available. Known
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correlations for properties of water, propylene glycol, and ethylene glycol can be used in the next 
round of simulations as starting points. In addition to the fluid properties being refined in the 
model, the non-Newtonian properties of blood can be incorporated into the model. The pulsatile 
nature of blood flow can also be incorporated into the model by modeling the unsteady 
governing equations. The energy conservation should be added to the modeling to take 
temperature effect into account.
In addition to improvements to the fluid properties of the system, the properties of the aorta wall 
should be updated. The aorta wall is not a solid no-slip surface. It is a complicated biological 
system that may impact how the blood flows through the aorta. Another step that should be 
taken is creating a 3-dimensional model of the aorta itself and run simulations with the refined 
boundary conditions and fluid properties.
Further study is required to understand how gold nanoparticles will affect the body. In spite of 
the fact that gold nanoparticles of a certain size may not be toxic to a patient, even a 1% volume 
concentration in the blood system would lead to serious complications as the nanoparticles 
migrate to internal organs and become embedded. The human body has a threshold of tolerance 
for foreign objects. Research should be done to determine what concentration of gold 
nanoparticles can be tolerated by the human body. Part of this study should be research into how 
these nanoparticles can be efficiently extracted from the body once they are no longer required. 
We also need an understanding of how modified properties of blood due to the introduction of 
nanoparticles to the system will affect the health of a patient.
There has been extensive research conducted in understanding how nanoparticles affect the 
thermophysical properties of a fluid. This area of research should be expanded to include 
nanoparticles that could be used for therapeutic medical applications and how they affect the 
thermophysical properties of blood.
This area of research is multidisciplinary. Not any one field will be able to answer all of the 
questions when it comes to how nanoparticles can be used on human patients. However, it is 
definitely worth pursuing as any tool in the fight against cancer is extremely important.
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Appendix A contains the results of 20 ANSYS Fluent computational runs. The results appear in 
order starting from a fluid temperature of 30 degrees Celsius and ending at 40 degrees Celsius. 




Figure 22: Velocity contour at 30 degrees Celsius
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Figure 23:Velocity vector fie ld  at 30 degrees Celsius
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Figure 24: Velocity contour at 31 degrees Celsius
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Figure 25:Velocity vector fie ld  at 31 degrees Celsius
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Figure 26: Velocity contour at 32 degrees Celsius
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Figure 27:Velocity vector fie ld  at 32 degrees Celsius
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Figure 28: Velocity contour at 33 degrees Celsius
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Figure 29:Velocity vector fie ld  at 33 degrees Celsius
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Figure 30: Velocity contour at 34 degrees Celsius
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Figure 31:Velocity vector fie ld  at 34 degrees Celsius
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Figure 32: Velocity contour at 35 degrees Celsius
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Figure 33:Velocity vector fie ld  at 35 degrees Celsius
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Figure 34: Velocity contour at 36 degrees Celsius
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Figure 35:Velocity vector fie ld  at 36 degrees Celsius
54
Figure 36: Velocity contour at 37 degrees Celsius
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Figure 37:Velocity vector fie ld  at 37 degrees Celsius
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Figure 38: Velocity contour at 38 degrees Celsius
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Figure 39:Velocity vector fie ld  at 38 degrees Celsius
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Figure 40: Velocity contour at 39 degrees Celsius
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Figure 41:Velocity vector fie ld  at 39 degrees Celsius
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Figure 42: Velocity contour at 40 degrees Celsius
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Figure 43:Velocity vector fie ld  at 40 degrees Celsius
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